TrueBlue (TBI) delivered earnings and revenue surprises of 52.17% and 0.19%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Sense Neuro Diagnostics, a leader in developing technology for the diagnosis and monitoring of brain injuries, today announced it has been awarded a $2 million contract by the Department of Defense ...